Seòmar agus comataidhean

Scottish Ministers issued National Directions on annual health checks, which state that the Scottish Health Check for Adults with Learning Disabilities documentation must be used in every health check. This documentation was tested and evidenced throughout the pilot phase and provides comprehensive best practice information and guidelines for practitioners, including on the specific health needs of people with Down’s Syndrome. This maintains the consistency and efficacy of each annual health check whilst also enabling practitioners to incorporate the specific health needs of each individual.

The Scottish Government has commissioned NHS Education for Scotland (NES) to support practitioners to complete annual health checks.

The Scottish Government continues to fund Down’s Syndrome Scotland to develop resources and accessible information about annual health checks for people with Down’s Syndrome, their families and carers, and for practitioners.

The Scottish Government recognises that the ability to attract and deliver innovative clinical research studies is vital to improving healthcare and patient outcomes. We therefore welcome Lord O’Shaughnessy’s review into commercial clinical trials in the UK. We will engage with partners across the UK in the coming weeks to understand how we can work together to ensure the review’s recommendations are considered for Scotland.

The Scottish Government recognises that the ability to attract and deliver innovative clinical research studies is vital to improving healthcare and patient outcomes. We therefore welcome Lord O’Shaughnessy’s review into commercial clinical trials in the UK. We will engage with partners across the UK in the coming weeks to understand how we can work together to ensure the review’s recommendations are considered for Scotland.

Following searches by Scottish Government officials on the corporate system, 5 complaints have been identified which relate to ‘medical’ or ‘medical devices’ and ‘power. However it should be noted that complaints of this nature are more likely to be directed to health boards as providers of such devices.

We are developing an International Culture Strategy with stakeholders, including our international offices and Creative Scotland, that will support the international aspirations and potential of the culture sector in Scotland and build on its strong international footprint.

The Scottish Government’s Chief Scientist Office invests through NHS Research Scotland in the Scottish Health Research Register and Biobank (SHARE) to support the recruitment of people into health research studies and clinical trials. SHARE is an expanding register of over 300,000 people who have expressed an interest in participating in health research and have agreed to be contacted about studies to which they might be suited.

Data produced by SHARE shows ethnic and socioeconomic distributions supportive of inclusive recruitment to health research studies. CSO is also funding an ongoing project by the University of Aberdeen looking at ways to improve ethnic diversity in clinical trials and to help trial teams recruit and retain ethnic groups in studies.

In addition, In February 2023, the Scottish Government published an independent report on Equity of Access to Cancer Clinical Trials in Scotland. The report contains 51 recommendations, with an Implementation Board established to prioritise these and develop an implementation strategy. While the report focuses on cancer clinical trials, many of the recommendations are relevant across the clinical spectrum.

We published an update on our progress delivering the recommendations from the National Review of Eating Disorder Services in April 2023. This can be found here: National Review of Eating Disorder Services Implementation Group: final report - gov.scot (www.gov.scot) .

We have made good progress responding to the short-term recommendations made by the National Review and will shortly establish the National Eating Disorder Network which will support us to deliver on the remaining long-term recommendations.

Since the Review published in 2021, we have:

• Provided funding to NHS Boards, including £5 million in 2021/22 to respond to the rise in eating disorder referrals we saw during the pandemic, and £46 million in 2022/23 via the 2022-23 Mental Health Outcomes Framework to improve the quality and delivery of mental health and psychological services, including eating disorder services.
• Established the Eating Disorder Lived Experience Panel to support us to deliver the remaining recommendations from the National Review.
• Initiated the development of Quality Standards for Eating Disorder Care and Treatment in Scotland (which we will be consulting on this summer).
• Provided over £600,000 annually to Beat to provide a range of self-help and carer support programmes in Scotland.
• Commissioned NHS Benchmarking to undertake a “deep dive” into Eating Disorders services and their data, to support us to target future funding appropriately.

The Mental Health and Wellbeing Strategy was published on 29 June 2023, along with an Executive Summary and Easy Read version. A programme of stakeholder engagement will take place over the Summer on the accompanying Delivery Plan, with the intention of publishing it alongside the Workforce Action Plan in the Autumn. The Strategy is available online at Mental health and wellbeing strategy - gov.scot (www.gov.scot) .

The Workforce Short Life Working Group set up through the Managed Service Network for Children and Young People with Cancer (MSN CYPC) has now concluded and no future meetings are planned.

As agreed by the MSN Board a Workforce Planning and Development Group will be established to review the pharmacy and Allied Healthcare Professional lead roles which were proposed as part of the 2020 workforce plan but have yet to be recruited to. This Group will also focus on education and training for the wider MSN CYPC community.

Scottish Government’s Chief Scientist Office engages regularly with UK Government and agencies directly, and through cross-UK fora, on streamlining the clinical trials system across the UK. These discussions cover a range of topics, recently including post-pandemic growth, clinical trial regulations, research ethics review, and commercial trial costing and contracting – where Scotland’s already existing single price model for commercial research is informing work to realise a streamlined, standardised, UK approach.